Computed Tomography Vs. Endoscopy Study
Launched by SPITAL LIMMATTAL SCHLIEREN · May 8, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods—endoscopy and CT scans—to see which one is better at detecting leaks that can occur after surgery for colon problems. If you agree to participate, you would have either of these tests done on days 3, 4, or 5 after your surgery. The goal is to find out which method is more accurate in spotting any potential complications. After the tests, you would be followed up until day 42 after your surgery to monitor your recovery.
To be eligible for this study, you need to be at least 18 years old and scheduled for elective surgery to remove part of your left colon, with plans to reconnect the remaining parts. However, if you had a stoma created during surgery or certain kidney issues, you wouldn't be able to participate. The study will provide you with all the information you need and obtain your consent before moving forward. It’s important to note that the study is currently looking for participants, and everyone is welcome to join, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Laparoscopic or open left sided colorectal resection with primary anastomosis (left hemicolectomy, sigmoid resection, anterior resection, segmental resection) and subtotal colectomy with anastomosis
- • Male and Female patients \>18 years of age
- • Signed Informed Consent after being informed
- • Elective surgery
- Exclusion Criteria:
- • Formation of a stoma during the initial operation
- • For i.v. contrast CT scan: creatinine \> 110 umol/l and/or glomerular filtration rate GFR \< 45 ml/min, measured in the standard blood test on postoperative day 2
- • Women who are pregnant. Women of childbearing age are regularly tested for possible pregnancy. Pregnancy tests are performed in the hospital at no charge
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- • Participation in another study with an investigational drug within the 30 days preceding and during the present study
- • Emergency intervention
About Spital Limmattal Schlieren
Spital Limmattal Schlieren is a leading healthcare institution dedicated to delivering high-quality medical services and advancing clinical research. Located in Switzerland, the hospital specializes in a range of medical disciplines and is committed to improving patient outcomes through innovative treatments and therapies. As a clinical trial sponsor, Spital Limmattal Schlieren actively engages in research initiatives that aim to enhance medical knowledge and contribute to the development of new therapeutic options, ensuring adherence to rigorous ethical standards and regulatory requirements. With a focus on collaboration and excellence, the institution fosters an environment that supports scientific inquiry and promotes the health and well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Schlieren, Zh, Switzerland
Patients applied
Trial Officials
Urs Zingg, Prof. Dr. med.
Principal Investigator
Head of department (surgery)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials